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Abstract
Purpose In prosthetic joint infections (PJIs) of the knee,
debridement with implant retention is associated with a high
risk of recurrence.
Methods A single-centre cohort study was performed with
extensive analysis of the literature covering 1980–2012.
Results In 21 patients (mean age 80.4 years, 19
immunosuppressed), in association with 1.5–three months
of antibiotic treatment, an attempt was made to salvage the
prosthesis by open (11 patients) or arthroscopic (ten pa-
tients) debridement. After a mean follow-up of seven years
(range four–20 years), patients were in remission in seven
cases (33 %). Remission was achieved in 0 % of all
methicillin-resistant Staphylococcus aureus (MRSA) infec-
tions (zero/three), in 0 % (zero/three) of methicillin-resistant
coagulase-negative staphylococcal infections, in 29 %
(two/seven) of methicillin-sensitive S. aureus infections
and in 75 % (three/four) of infections due to streptococci.
The literature review focused on implant preserving ap-
proaches yielded 599 cases with an overall success rate of
47 % (284/599) and significantly more remissions in strep-
tococcal vs staphylococcal knee PJIs (43/54 vs 144/324; p<
0.01, odds ratio 4.9, 95 % confidence interval 2.4–10.9).
Conclusions In addition to established indications for ex-
plantation such as implant loosening, sinus tract or methi-
cillin resistance, the decision for debridement and retention
of knee PJIs should also depend on the pathogen. Implant
preservation is futile with methicillin-resistant staphylococci,
but seems to be a valid option for streptococcal PJIs.
Introduction
Orthopaedic surgeons treat prosthetic joint infections (PJIs)
choosing between four general approaches: one- or two-stage
exchanges, debridements with prosthesis retention or lifelong
oral antibiotic suppressive therapy [1]. The option of debride-
ment with implant retention harbours a higher risk of infection
recurrence than procedures with implant removal, especially
for knee PJIs [1, 2]. Provided that the duration of infection is
shorter than two to four weeks, there is no sinus tract, implant
loosening or methicillin resistance among staphylococci [1, 3,
4], the debridement and irrigation approach may also be a
valid alternative for elderly patients with less bone stock [5]
and multiple co-morbidities, for whom anaesthesia and sur-
gery could be harmful [1].
However, the chances of success with prosthesis reten-
tion remain controversial, with remission rates ranging be-
tween 11 [6] and 86 % [7]. Only small case series with
short-term follow-ups may yield remissions of 100 % [8],
and interestingly papers in medical journals [7, 9–12] show
higher success rates than those published is surgical journals
[3, 5, 13–15]. Many of these papers have substantial short-
comings. They mix up hip and knee arthroplasties [10, 12],
reveal short minimal follow-up times of only several months
[4, 11, 13, 16, 17], report less than ten cases [8, 13, 18–20]
or report only specific pathogens [7, 9] such as methicillin-
resistant Staphylococcus aureus (MRSA) [1, 3].
Another important factor frequently neglected in the
choice of preservation versus non-preservation of the im-
plant is the inherent role of the pathogen species per se. With
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a few microbiological exceptions such as mycobacteria,
fungi or possibly staphylococcal methicillin resistance [3,
15, 20, 21], the surgeon's approach to the management of
PJIs is very often pathogen independent [1]. According to
existing literature and experts’ recommendations, neither the
duration of concomitant antibiotic prescription nor the
choice of the surgical approach rely on species identification
[1]. In contrast, clinical experience suggests a much better
outcome with streptococcal PJI. This impression is poorly
investigated. Two papers [16, 22] suggest a high remission
chance in streptococcal knee PJIs, but do not compare them
directly with other pathogens. Other articles may hint at a
better outcome in streptococcal disease, but do not investigate
it [8, 14, 20].
In this single-centre cohort study and extensive literature
review covering 1980–2012, we hypothesise that retention
of total knee PJIs is futile for staphylococcal PJIs (MRSA or
methicillin-sensitive S. aureus) [3, 9–11, 15, 20], but is a
more than valid option for streptococcal PJIs [16, 22].
Setting and methods
The Geneva University Hospitals that conduct a total joint
arthroplasty cohort also supported this study (No. Ethics
Committee 08–057). Diagnosis of PJI is based upon the
presence of intraoperative pus together with clinical signs
of infection (new onset of pain, fever, discharge and/or
radiographic signs of prosthesis loosening). Identification
of the infecting organism requires the same pathogen to be
present in at least two intra-operative samples. Remission is
defined as the absence of any clinical, laboratory or radio-
logical signs of recurrence after a minimal follow-up of
two years. In our institution, whenever the decision for
surgical revision with implant preservation is taken, infected
arthroplasties are debrided by arthroscopy or arthrotomy
with synovectomy and irrigation with nine litres NaCl
0.9 %. The procedure may be repeated after two to
five days if there is no substantial decrease in local and
systemic inflammation after the first intervention.
A literature review searching for all English-language
scientific papers in PubMed and the Internet without time
restriction was performed. References of retrieved articles
were hand-searched for additional information. Important
requirements were a linked outcome to underlying pathogens
and attempts at implant retention based on a few recommen-
dations: duration of infection shorter than three to four weeks,
absence of a sinus tract or of implant loosening [1]. Articles
without detailed information regarding microbiology, out-
come or treatment modalities in human cases were excluded,
as were opinion papers without the author’s own data or
desperate isolated attempts at implant retention against inter-
national experts’ guidelines [1].
Local results
A total of 21 total knee PJIs in 21 patients, treated with
debridement and implant retention, within three weeks of
infection onset, were retrieved between 1996 and 2006 (ten
men and 11 women, mean age 80 years) (Table 1). There
were no unicompartmental knee joint replacements. As op-
posed to the implant explantation-reimplantation approach,
the debridement and irrigation approach has been individu-
ally chosen as being considered less aggressive than the
standard one- or two-stage arthroplasty exchange procedure.
The patients showed significant co-morbidities and immu-
nosuppression: diabetes mellitus (n=five), obesity (three),
alcoholism (two), active cancer (three), autoimmune disease
requiring steroids (two) and severe undernourishment
(four), as defined by a serum albumin concentration
<15 mmol/L. None of the PJIs showed radiological signs
of loosening, of fistula or of a sinus tract.
The mean delay between arthroplasty and first clinical
signs of PJI was two years (range, nine days–12 years).
Overall, two PJIs occurred after a delay of three months
following prosthesis implantation. Twelve (57 %) occurred
between three months and two years, and seven (33 %) oc-
curred after two years post-arthroplasty according to the val-
idated criteria of Zimmerli et al. [1]. All PJIs were treated with
a targeted antibiotic therapy for a mean duration of nine weeks
(range six–12 weeks) and underwent one to two debridements
(arthrotomies in 11 patients and arthroscopies in ten patients).
After a mean active follow-up of seven years (range four–
20 years), patients were in remission in only seven cases (7/21,
33%). The 14 recurrences occurred on average after 5.4months
post-antibiotic therapy (range 0.5–17 months) and were due to
the same pathogen as during the first episode. However, this
low success rate differed according to the microbiological strata
(Table 1). Remission was achieved in 0 % of all MRSA in-
fections (zero/three), in 0 % (zero/three) of methicillin-resistant
coagulase-negative staphylococcal infections and in 29 %
(two/seven) of methicillin-sensitive S. aureus infections, but
in 75 % (three/four) of infections due to streptococci. The
difference between staphylococci and streptococci showed a
trend [Fisher’s exact test p=0.09, odds ratio 0.1, 95 % confi-
dence interval (CI) 0.1–2.1], whereas the duration of antibiotic
prescription (six weeks vs 12 weeks) did not influence remis-
sion chances (three/seven vs four/seven, p=1.0).
Literature review
We identified 27 articles (28 together with the present one)
matching our search criteria and describing in full detail the
experience of the authors with debridement and retention of
infected knee PJIs (Table 2). We found seven additional
papers describing this approach, but without detailed
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information about the proportion of knee and hip PJIs or the
causative pathogen. These papers were excluded from anal-
ysis. Finally, our literature review involved 599 cases. The
majority was infected with methicillin-susceptible S. aureus
and treated with arthroscopic or open debridement
(arthrotomy) in at least 274 cases. The duration of concom-
itant antibiotic therapy peaked around two months (Table 2).
Overall remission chance averaged 47 % (284/599), but it
differed in favour of streptococcal infections compared to
staphylococcal PJIs [43/54 (80 %) vs 144/324 (44 %)]. This
difference was highly significant (χ2 test p<0.01, odds ratio
4.9, 95 % CI 2.4–10.9) (Table 3).
Discussion
Our long-term follow-up data and literature review suggest
that debridement and retention of knee PJIs may be ineffi-
cient for MRSA infections [3, 15], moderately successful for
methicillin-sensitive S. aureus infections [7, 9, 14, 23], but a
valid option for streptococcal PJIs [8, 16]. The odds for
succeeding with implant retention for streptococcal PJIs
compared to staphylococcal infections (methicillin-suscepti-
ble S. aureus and coagulase-negative staphylococci included)
were fivefold. This is an encouraging message for clinicians
and hospital administrators. At the same time, our review
underlined a non-negligible probability of implant preservation
failure for patients infected withMRSA or other staphylococci.
The better outcome with streptococcal disease has been
suggested, even if not fully investigated, in other single-
centre studies. Meehan et al. revealed only an 11 % relapse
rate with debridement and implant retention among 19
streptococcal knee PJIs [16]. Ilahi et al. reported a ubiqui-
tous remission with implant retention among five patients,
of whom four were infected due to streptococci [8].
Research groups from the USA [14, 22] and Japan [20]
mentioned 100 % success rates among patients infected with
streptococci, but less for those infected with staphylococci.
However, it should not be forgotten that a better success
with streptococcal knee PJI is not ubiquitously displayed.
There are also smaller series denying a better outcome [13]
or demonstrating a worse outcome [23] of streptococcal
infection as compared to S. aureus.
The literature is sparse when it comes to the explanation
of why streptococcal infections have a better outcome than
staphylococcal infections (especially methicillin-resistant
infections). This might be surprising, considering that sur-
gical debridement, viewed as the most important measure, is
pathogen independent in its nature. From a theoretical point
of view, methicillin-resistant infection might yield a higher
Table 1 Prosthetic knee joint infections treated with debridement and implant retention at Geneva University Hospitals
Case no. Delay between implantation and infection Main pathogen 1st debridement 2nd debridement Recurrence
1 9 days MSSA Arthroscopy No
2 21 days Escherichia coli Arthrotomy No
3 4 months MRSA Arthroscopy Yes
4 4 months MSSA Arthroscopy Yes
5 5 months Streptococcus agalactiae Arthrotomy No
6 9.5 months MRSA Arthrotomy Arthrotomy Yes
7 9.5 months Streptococcus agalactiae Arthroscopy Arthroscopy No
8 11.5 months MRSA Arthrotomy Arthrotomy Yes
9 12 months CoNS Arthroscopy Yes
10 12.5 months CoNS Arthrotomy Yes
11 16 months MSSA Arthrotomy Arthrotomy Yes
12 17 months MSSA Arthroscopy Yes
13 19 months MSSA Arthrotomy Arthrotomy Yes
14 19 months MSSA Arthroscopy Arthroscopy No
15 2.4 years CoNS Arthrotomy Arthrotomy Yes
16 4 years MSSA Arthroscopy No
17 6 years MSSA Arthrotomy Yes
18 6.4 years Clostridium septicum Arthrotomy Yes
19 7.2 years Pasteurella multocida Arthroscopy Yes
20 10 years Group G Streptococcus Arthrotomy No
21 12 years Streptococcus milleri Arthroscopy Yes
MSSA methicillin-sensitive Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, CoNS coagulase-negative staphylococci
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recurrence risk [9], because available antimicrobial agents
(e.g. vancomycin) reveal diminished bactericidal activity
compared to antibiotics against sensitive microorganisms
[21]. But this fact does not appear sufficient to explain the
outcome differences between sensitive staphylococci and
streptococci, inasmuch as physicians and surgeons use almost
the same antibiotic classes for both. Here, the capacity of
biofilm formation may play a role. According to our current
understanding, biofilm formation is more enhanced in staph-
ylococcal foreign body infections than in streptococcal PJIs
[24]. Other, yet unexplored physiopathological mechanisms
are most probably involved in this respect.
As a conclusion, based upon our findings, we believe that
the identified pathogen (and not merely its methicillin resis-
tance [1, 3, 5, 15]) should influence the decision for pros-
thesis retention in knee PJIs, besides consideration of the
patient’s general condition, sinus tracts, implant loosening
or chronicity of the infection. We thus disregard retention in
cases of knee PJI for all staphylococcal disease and feel
relatively comfortable in cases of streptococcal disease.
Further studies are needed to confirm this presumption or
to identify other pathogens with equally better outcomes in
cases of implant retention.
Table 2 Literature review of 1980–2012: management of infected prosthetic knee joints with debridement/retention
First author No. of
prostheses
Main
pathogen
Arthrotomy
(vs arthroscopy)
Duration of antibiotic
treatment
Remission Minimal
follow-up
Teeny [2] 21 MSSA – 0.7–2 months 6 (29 %) 12 months
Bradbury [3] 19 MRSA 19 (100 %) 1.0–1.5 months 3 (16 %) 24 months
Dixon [4] 15 MSSA 0 (0 %) 3–16 months 9 (60 %) 4 months
Deirmengian [5] 31 MSSA 31 (100 %) 1.5 months 11 (35 %) 24 months
Woods [6] 27 MSSA – 1.0–1.5 months 3 (11 %) 36 months
Aboltins [7] 7 MSSA/MRSA 7 (100 %) 12 months 6 (86 %) 12 months
Ilahi [8] 5 Streptococci 0 (0 %) 2.0–2.5 months 5 (100 %) 36 months
Barberán [9] 28 CoNS – 1.5–3 months 19 (68 %) 12 months
Byren [10] 51 MSSA - 18 months 38 (75 %) 3 months
Cobo [11] 46 MSSA – 1.5–3 months 29 (63 %) 0 month
Vidil [13] 5 MSSA 0 (0 %) 3 months 2 (40 %) 6 months
Waldman [14] 16 MSSA 0 (0 %) 1.5 months 6 (38 %) 36 months
Siddiqui [15] 12 MRSA 12 (100 %) 1.5 months 4 (33 %) 24 months
Meehan [16] 13 Streptococci – 0.5–1.2 months 12 (92 %) 4 months
Schoifet [17] 31 MRSA 31 (100 %) 2 months 7 (23 %) 7 months
Freeman [18] 6 MSSA – 3 months 5 (83 %) 12 months
Flood [19] 2 MSSA 0 (0 %) – 2 (100 %) 30 months
Tsumura [20] 9 MRSA 0 (0 %) – 7 (78 %) 13 months
Burger [22] 39 MSSA 39 (100 %) 0.5–2 months 7 (18 %) 12 months
Chiu [23] 40 MRSA 40 (100 %) 1.5 months 12 (30 %) 36 months
Tattevin [25] 34 MSSA – – 13 (38 %) 12 months
Hartman [26] 33 MSSA 32 (97 %) 0.5–3 months 20 (61 %) –
Rasul [27] 10 CoNS – 1.0–1.5 months 4 (40 %) 24 months
Mont [28] 24 MSSA 24 (100 %) 1.5–3 months 20 (83 %) 48 months
Wilson [29] 31 MSSA 23 (74 %) – 17 (55 %) 24 months
Borden [30] 11 MSSA – – 5 (45 %) –
Grogan [31] 12 MSSA 5 (42 %) – 5 (42 %) 18 months
This article 21 MSSA 11 (55 %) 1.5–3 months 7 (33 %) 24 months
Total/average 599 MSSA 274 (46 %) 2 months 284 (47 %) 19 months
MSSA methicillin-sensitive Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, CoNS coagulase-negative staphylococci
Table 3 Comparison of recurrence stratified between staphylococci
and streptococci (literature review and our own cases)
Remission of
arthroplasty
infection
Recurrence of
arthroplasty
infectiona
Streptococci, n=54 43 11
Staphylococci, n=324 144 180
a Literature review of this article and references [3–5, 7–9, 13–15, 18,
20, 22, 23, 26, 28]
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